Just 2 years after GN guidelines were published in 2021, KDIGO dropped the most updated guidelines on the management of Lupus Nephritis. Besides Cyclophosphamide and Mycophenolate, Vocolosporin and Belimumab are now recommended as initial agents for the treatment of Class III and Class IV LN. Dr. Rovin discusses the evidence behind this major upgrade in the status of these two drugs. With more choices come more responsibilities!
Find out more about Dr. Rovin’s approach to the induction regimen and the emerging therapies in LN he is most excited about.
Visit us 👇
www.glomcon.org
my.glomcon.org
